MTHFR shows higher methylation levels in tumor tissue respect to blood (p = 0.007), and DNMT3A shows about 10% promoter methylation in tumor tissue but is completely demethylated in blood (p < 0.0001). This evidence concerns the gene DNMT3A and neoplasm.